FDA-Mandated 5-Year watch on new duchenne drug
Knowledge-focused
Recruiting now
This study will observe 300 patients with Duchenne muscular dystrophy (DMD) who are already taking the approved drug givinostat as part of their regular care. Researchers will track patients for up to 5 years to understand the drug's real-world safety, especially regarding low pl…
Sponsor: ITF Therapeutics LLC • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC